BG9928 in Subjects With Hepatic Impairment
NCT00858156
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Impairment
Interventions
DRUG:
BG9928
Sponsor
Biogen